F-Star Therapeutics Inc - ESG Rating & Company Profile powered by AI
This webpage contains a questions and answers section about F-Star Therapeutics Inc. The Sustainability rating for F-Star Therapeutics Inc indicates its transparency towards the United Nations Sustainable Development Goals. This analysis of F-Star Therapeutics Inc is prepared by All Street Sevva using leading machine learning.
F-Star Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | F-Star Therapeutics Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does F-Star Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Does F-Star Therapeutics Inc disclose current and historical energy intensity?
Does F-Star Therapeutics Inc report the average age of the workforce?
Does F-Star Therapeutics Inc reference operational or capital allocation in relation to climate change?
Does F-Star Therapeutics Inc disclose its ethnicity pay gap?
Does F-Star Therapeutics Inc disclose cybersecurity risks?
Does F-Star Therapeutics Inc use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does F-Star Therapeutics Inc offer flexible work?
Does F-Star Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does F-Star Therapeutics Inc disclose the number of employees in R&D functions?
Does F-Star Therapeutics Inc plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does F-Star Therapeutics Inc conduct supply chain audits?
Does F-Star Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does F-Star Therapeutics Inc conduct 360 degree staff reviews?
Does F-Star Therapeutics Inc disclose the individual responsible for D&I?
Does F-Star Therapeutics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does F-Star Therapeutics Inc disclose current and / or historical scope 2 emissions?
Does F-Star Therapeutics Inc disclose water use targets?
Does F-Star Therapeutics Inc have careers partnerships with academic institutions?
Did F-Star Therapeutics Inc have a product recall in the last two years?
Does F-Star Therapeutics Inc disclose incidents of discrimination?
Does F-Star Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Has F-Star Therapeutics Inc issued a profit warning in the past 24 months?
Does F-Star Therapeutics Inc disclose parental leave metrics?
Does F-Star Therapeutics Inc disclose climate scenario or pathway analysis?
Does F-Star Therapeutics Inc disclose current and / or historical scope 1 emissions?
Does F-Star Therapeutics Inc explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does F-Star Therapeutics Inc disclose the pay ratio of women to men?
Does F-Star Therapeutics Inc support suppliers with sustainability related research and development?
Does F-Star Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does F-Star Therapeutics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is F-Star Therapeutics Inc involved in embryonic stem cell research?
Does F-Star Therapeutics Inc disclose GHG and Air Emissions intensity?
Does F-Star Therapeutics Inc disclose its waste policy?
Does F-Star Therapeutics Inc report according to TCFD requirements?
Does F-Star Therapeutics Inc plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does F-Star Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does F-Star Therapeutics Inc disclose energy use targets?
Does F-Star Therapeutics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does F-Star Therapeutics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for F-Star Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.